February 2025
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways
One study found that compounded drugs were responsible for 45 percent of drug recalls in the US between 2012 and 2021, despite accounting for just 1 to 3 percent of prescriptions
Comprehensive Wellness Solutions: Beyond B12 shots, delve into our array of wellness offerings
When a facility administers the survey directly (without a vendor), it may leverage existing survey tools that include features that protect patient anonymity
Several commenters asserted that removing the measure would signal a retreat from CMS' stated goals of reducing disparities and improving care for vulnerable populations, including those with severe mental illness, racial and ethnic minorities, rural populations, those with low socioeconomic status, and dual eligible beneficiaries
